Bone marrow stem cells (BMSCs) have been used to treat patient with ST-segment elevation myocardial infarction (STEMI) via intracoronary route. We performed a meta-analysis to evaluate the short-term efficacy and safety of this modality. Seventeen randomized controlled trials (RCTs) of BMSC-based therapy for STEMI, delivered with 9 days of reperfusion and followed up shorter than 12 months, were identified by systematic review. Intracoronary BMSC therapy resulted in an overall significant improvement in left ventricular ejection fraction (LVEF) by 2.74 % (95 % confidence interval (CI) 2.09–3.39, P < 0.00001, I 2 = 84 %) at 3–6-month follow-up and 5.1 % (95 % CI 4.16–6.03, P < 0.00001 and I 2 = 85 %) at 12 months. The left ventricular end-systolic volume (LVESV) and wall motion score index (WMSI) were also reduced at 3–6 months. At 12 months, left ventricular end-diastolic volume (LVEDV), LVESV, and WMSI were significantly reduced in BMSC group. In conclusion, intracoronary BMSC therapy at post-STEMI is safe and effective in patient with acute STEMI.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Jeevanantham, V., & Butler, M.-L.-S. (2012). Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation, 126(5), 551–68.
Janssens, S., & Dubois, C. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet, 367, 117–121.
Ren, G., Micheal, L., Entman, M., & Frangogiannis, N. G. (2002). Morphological characteristics of the microvasculature in healing myocardial infarcts. The Journal of Histochemistry and Cytochemistry, 50(1), 71–79.
O'Gara, P., Kushner, F., Ascheim, D., Casey Jr, D. E., Chung, M., de Lemos, J., et al. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Founda. Circulation, 127(4), e362–425.
1.Allgower, M. (1956). In M. Allgower, The cellular basis of woun repair. Charles C. Thomas.
15.Jiang, Y., Jahagirdar, B., Reinhardt, R., Schwartz, R., Keene, C., Ortiz-Gonzalez, X., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. 418 (6893), 41-49.
Krause, D., Theise, N., Collector, M., Henegariu, O., Hwang, S., Gardner, R., et al. (2001). Multi-organ, multi- lineage engraftment by a single bone marrow-derived stem cell. Cell, 105(3), 369–377.
29.Quaini, F., Urbanek, K., Graiani, G., Lagrasta, C., Maestri, R., Monica, M., et al. (2004). The regenerative potential of the human heart. 95 (1), S26-S28.
Goodell, M., Jackson, K., Majka, S., Mi, T., Wang, H., Pocius, J., et al. (2001). Stem cell plasticity in muscle and bone marrow. Annals of the New York Academy of Sciences, 938, 208–218.
Jeong, H., & Yim, H. (2013). The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction. Stem Cell Research & Therapy, 4(4), 82.
Cao, F., & Sun, D. (2009). Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal, 30(16), 1986–94.
Clifford, D. M., & Fisher, S.-R. (2012). Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PloS One, 7(5), e37373.
Dill, T., & Schächinger, V. (2009). Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. American Heart Journal, 157(3), 541–7.
Sun, D., & Narsinh, K. (2013). Effect of autologous bone marrow mononuclear cells transplantation in diabetic patients with ST-segment elevation myocardial infarction. International Journal of Cardiology, 167(2), 537–47.
Leistner, D. M., & Fischer-Rasokat, U. (2011). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clinical Research in Cardiology, 100(10), 925–34.
Herbots, L., & D’hooge, J. (2009). Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. European Heart Journal, 30(6), 662–70.
Hirsch, A., Nijveldt, R., & Investigators, H. (2011). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE. European Heart Journal, 32(14), 1736–47.
Schachinger, V., Erbs, S., & REPAIR-AMI Investigators. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 4, 1210–1221.
Sürder, D., & Manka, R. (2013). Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation, 127(19), 1968–79.
Meluzín, J., & Janousek, S. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology, 128(2), 185–92.
Roncalli, J., & Mouquet, F. (2011). Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. European Heart Journal, 32(14), 1748–57.
de Jong, R., Houtagraaf, J. H., Samiei, S., Boersma, E., & Duckers, H. J. (2014). Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circulation. Cardiovascular Interventions, 7(2), 156–67.
Martin-Rendon, E., & Brunskill, S. (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. European Heart Journal, 29(15), 1807–18.
Huang, R. C., & Yao, K. (2007). Evaluation of myocardial viability with 201Tl/18F-FDG DISA-SPECT technique in patients with acute myocardial infarction after emergent intracoronary. Zhonghua Xin Xue Guan Bing Za Zhi, 35(6), 497–9.
Zimmet, H., & Porapakkham, P. (2012). Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. European Journal of Heart Failure, 14(1), 91–105.
Lebeau, R., & Serri, K. (2012). Assessment of left ventricular ejection fraction using the wall motion score index in cardiac magnetic resonance imaging. Archives of Cardiovascular Diseases, 105(2), 91–8.
Møller, J. E., & Hillis, G. (2006). Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction. American Heart Journal, 151(2), 419–25.
Zhang SN, S. A., Ge, J. B., Yao, K., Huang, Z. Y., Wang, K. Q., et al. (2009). Intracoronary autologous bone marrow stem cell transfer for patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. International Journal of Cardiology, 136, 178–85.
Zhang, C., Sun, A., Zhang, S., Yao, K., Wu, C., Fu, M., et al. (2010). Efficiency and safety of intracoronary autologous bone marrow-derrived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. Clinical Cardiology, 33, 353–60.
Halkin, A., Mandeep, S., Mikolsky, E., Grines, C. L., Tcheng, J. E., Garcia, E., Cox, D. A., et al. (2005). Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADLLAC risk score. Journal of the American College of Cardiology, 45, 1397–1405.
Meyer, G. P., & Wollert, K. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10), 1287–94.
Huikuri, H. V., Kervinen, K., & Investigators, F. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29(22), 2723–32.
Tendera, M., Wojakowski, W., & Investigators, R. (2009). Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by Intracor. European Heart Journal, 30(11), 1313–21.
Lunde, K., & Solheim, S. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1199–209.
Plewka, M., & Krzemińska-Pakula, M.-D. (2009). Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. The American Journal of Cardiology, 104(10), 1336–42.
Grajek, S. P. M.-M.-S. (2010). Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microc. European Heart Journal, 31(6), 691–702.
Traverse, J. H., & McKenna, D. (2010). Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. American Heart Journal, 160(3), 428–34.
Wöhrle, J., & Merkle, N. (2010). Results of intracoronary stem cell therapy after acute myocardial infarction. The American Journal of Cardiology, 105(6), 804–12.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Associate Editor Enrique Lara-Pezzi oversaw the review of this article
Rights and permissions
About this article
Cite this article
Cong, Xq., Li, Y., Zhao, X. et al. Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials. J. of Cardiovasc. Trans. Res. 8, 221–231 (2015). https://doi.org/10.1007/s12265-015-9621-9
- Cell therapy
- Stem cells
- Acute myocardial infarction